Rand: Typical Cost of Developing a New Drug Is Skewed by Few High-Cost Outliers
January 08, 2025
January 08, 2025
SANTA MONICA, California, Jan. 8 (TNSres) -- Rand issued the following news release on Jan. 7, 2025:
The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and development, according to a new RAND study (https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2828689).
Using a novel method to assess spending on research and deve . . .
The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and development, according to a new RAND study (https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2828689).
Using a novel method to assess spending on research and deve . . .